Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 4:01 PM ET

Date/Time Source News Release
06/11/2025 07:30 AM EDT GlobeNewswire Ocugen To Present at BIO International Convention 2025
06/05/2025 07:02 AM EDT GlobeNewswire Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
05/27/2025 07:02 AM EDT GlobeNewswire Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST-Modifier Gene Therapy for the Treatment of Stargardt Disease
05/09/2025 08:01 AM EDT GlobeNewswire Ocugen Provides Business Update with First Quarter 2025 Financial Results
05/02/2025 08:00 AM EDT GlobeNewswire Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
04/29/2025 07:30 AM EDT GlobeNewswire Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress
04/08/2025 08:02 AM EDT GlobeNewswire Ocugen to Present at the 2025 Cell & Gene Meeting on the Med
03/18/2025 08:02 AM EDT GlobeNewswire Data and Safety Monitoring Board Reviews Cohort 1 Safety Data and Approves Dosing Cohort 2 in the Clinical Trial of OCU200-a Novel Fusion Protein for Diabetic Macular Edema
03/06/2025 09:04 AM EST GlobeNewswire Attention Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); MGP Ingredients, Inc. (NASDAQ: MGPI); and Ocugen, Inc. (NASDAQ: OCGN): Grabar Law Office Investigates Claims on Your Behalf
03/05/2025 07:02 AM EST GlobeNewswire Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results
Page

Additional News

As of June 12, 2025 • 4:01 PM ET

Date/Time Source News Release
06/05/2025 09:32 AM EDT SeekingAlpha Ocugen signs license deal with Korean company for gene therapy
05/28/2025 09:50 AM EDT SeekingAlpha Editas Medicine, Cassava Sciences among healthcare stocks to join Russell Microcap; MNKD, OCGN to exit
05/28/2025 09:35 AM EDT SeekingAlpha Crispr Therapeutics, Clover Health among healthcare stocks to join Russell 3000; INO, SAVA to exit
05/27/2025 09:44 AM EDT SeekingAlpha Ocugen wins FDA rare pediatric disease status for genetic eye disorder treatment
05/10/2025 05:30 AM EDT US Earnings Reports Expected earnings - Ocugen, Inc.
05/09/2025 10:05 AM EDT SeekingAlpha Ocugen outlines 2025 milestones for gene therapy programs with BLA filings on track
05/09/2025 10:02 AM EDT SeekingAlpha Ocugen, Inc. (OCGN) Q1 2025 Earnings Call Transcript
05/09/2025 08:03 AM EDT SeekingAlpha Ocugen GAAP EPS of -$0.05 beats by $0.01, revenue of $1.48M
05/08/2025 06:48 PM EDT KlickAnalytics OCGN - Historical Price Movements Surrounding Earnings
05/08/2025 06:43 PM EDT KlickAnalytics OCGN - Historical Earnings Price Analysis
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.